|
1
|
Fong Y, Sun RL, Jarnagin W and Blumgart
LH: An analysis of 412 cases of hepatocellular carcinoma at a
Western center. Ann Surg. 229:790–800. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gerber B, Freund M and Reimer T: Recurrent
breast cancer: Treatment strategies for maintaining and prolonging
good quality of life. Dtsch Arztebl Int. 107:85–91. 2010.PubMed/NCBI
|
|
3
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells - perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Monteiro J and Fodde R: Cancer stemness
and metastasis: Therapeutic consequences and perspectives. Eur J
Cancer. 46:1198–1203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lapidot T, Sirard C, Vormoor J, Murdoch B,
Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and
Dick JE: A cell initiating human acute myeloid leukaemia after
transplantation into SCID mice. Nature. 367:645–648. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hermann PC, Huber SL, Herrler T, Aicher A,
Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations
of cancer stem cells determine tumor growth and metastatic activity
in human pancreatic cancer. Cell Stem Cell. 1:313–323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee TK, Castilho A, Cheung VC, Tang KH, Ma
S and Ng IO: CD24+ liver tumor-initiating cells drive
self-renewal and tumor initiation through STAT3-mediated NANOG
regulation. Cell Stem Cell. 9:50–63. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao W, Wang L, Han H, Jin K, Lin N, Guo
T, Chen Y, Cheng H, Lu F, Fang W, et al: 1B50-1, a mAb raised
against recurrent tumor cells, targets liver tumor-initiating cells
by binding to the calcium channel α2δ1 subunit. Cancer Cell.
23:541–556. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Inui M, Martello G and Piccolo S: MicroRNA
control of signal transduction. Nat Rev Mol Cell Biol. 11:252–263.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren D, Wang M, Guo W, Huang S, Wang Z,
Zhao X, Du H, Song L and Peng X: Double-negative feedback loop
between ZEB2 and miR-145 regulates epithelial-mesenchymal
transition and stem cell properties in prostate cancer cells. Cell
Tissue Res. 358:763–778. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ren D, Wang M, Guo W, Zhao X, Tu X, Huang
S, Zou X and Peng X: Wild-type p53 suppresses the
epithelial-mesenchymal transition and stemness in PC-3 prostate
cancer cells by modulating miR-145. Int J Oncol. 42:1473–1481.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma S, Tang KH, Chan YP, Lee TK, Kwan PS,
Castilho A, Ng I, Man K, Wong N, To KF, et al: miR-130b promotes
CD133+ liver tumor-initiating cell growth and
self-renewal via tumor protein 53-induced nuclear protein 1. Cell
Stem Cell. 7:694–707. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ji J, Yamashita T, Budhu A, Forgues M, Jia
HL, Li C, Deng C, Wauthier E, Reid LM, Ye QH, et al: Identification
of microRNA-181 by genome-wide screening as a critical player in
EpCAM-positive hepatic cancer stem cells. Hepatology. 50:472–480.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hahn WC, Dessain SK, Brooks MW, King JE,
Elenbaas B, Sabatini DM, DeCaprio JA and Weinberg RA: Enumeration
of the simian virus 40 early region elements necessary for human
cell transformation. Mol Cell Biol. 22:2111–2123. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo W, Ren D, Chen X, Tu X, Huang S, Wang
M, Song L, Zou X and Peng X: HEF1 promotes epithelial mesenchymal
transition and bone invasion in prostate cancer under the
regulation of microRNA-145. J Cell Biochem. 114:1606–1615. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang M, Ren D, Guo W, Huang S, Wang Z, Li
Q, Du H, Song L and Peng X: N-cadherin promotes
epithelial-mesenchymal transition and cancer stem cell-like traits
via ErbB signaling in prostate cancer cells. Int J Oncol.
48:595–606. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Gong LY, Song LB, Jiang LL, Liu LP,
Wu J, Yuan J, Cai JC, He M, Wang L, et al: Oncoprotein Bmi-1
renders apoptotic resistance to glioma cells through activation of
the IKK-nuclear factor-kappaB pathway. Am J Pathol. 176:699–709.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goodell MA: Stem cell identification and
sorting using the Hoechst 33342 side population (SP). Curr Protoc
Cytom Chapter. 9:Unit9.182005.
|
|
24
|
de Sousa E, Melo F, Colak S, Buikhuisen J,
Koster J, Cameron K, de Jong JH, Tuynman JB, Prasetyanti PR,
Fessler E, van den Bergh SP, et al: Methylation of
cancer-stem-cell-associated Wnt target genes predicts poor
prognosis in colorectal cancer patients. Cell Stem Cell. 9:476–485.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Simeone DM: Pancreatic cancer stem cells:
Implications for the treatment of pancreatic cancer. Clin Cancer
Res. 14:5646–5648. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mao J, Wang J, Liu B, Pan W, Farr GH III,
Flynn C, Yuan H, Takada S, Kimelman D, Li L, et al: Low-density
lipoprotein receptor-related protein-5 binds to Axin and regulates
the canonical Wnt signaling pathway. Mol Cell. 7:801–809. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gordon MD and Nusse R: Wnt signaling:
Multiple pathways, multiple receptors, and multiple transcription
factors. J Biol Chem. 281:22429–22433. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barker N, van Es JH, Kuipers J, Kujala P,
van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H,
Peters PJ, et al: Identification of stem cells in small intestine
and colon by marker gene Lgr5. Nature. 449:1003–1007. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wielenga VJ, Smits R, Korinek V, Smit L,
Kielman M, Fodde R, Clevers H and Pals ST: Expression of CD44 in
Apc and Tcf mutant mice implies regulation by the WNT
pathway. Am J Pathol. 154:515–523. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gangopadhyay S, Nandy A, Hor P and
Mukhopadhyay A: Breast cancer stem cells: A novel therapeutic
target. Clin Breast Cancer. 13:7–15. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takebe N, Miele L, Harris PJ, Jeong W,
Bando H, Kahn M, Yang SX and Ivy SP: Targeting Notch, Hedgehog, and
Wnt pathways in cancer stem cells: Clinical update. Nat Rev Clin
Oncol. 12:445–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lachenmayer A, Alsinet C, Savic R,
Cabellos L, Toffanin S, Hoshida Y, Villanueva A, Minguez B, Newell
P, Tsai HW, et al: Wnt-pathway activation in two molecular classes
of hepatocellular carcinoma and experimental modulation by
sorafenib. Clin Cancer Res. 18:4997–5007. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wong CM, Fan ST and Ng IO: beta-Catenin
mutation and overexpression in hepatocellular carcinoma:
Clinicopathologic and prognostic significance. Cancer. 92:136–145.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bafico A, Liu G, Yaniv A, Gazit A and
Aaronson SA: Novel mechanism of Wnt signalling inhibition mediated
by Dickkopf-1 interaction with LRP6/Arrow. NaT cell Biol.
3:683–686. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee J, Yoon YS and Chung JH: Epigenetic
silencing of the WNT antagonist DICKKOPF-1 in cervical
cancer cell lines. Gynecol Oncol. 109:270–274. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Na Y, Lee SM, Kim DS and Park JY: Promoter
methylation of Wnt antagonist DKK1 gene and prognostic value in
Korean patients with non-small cell lung cancers. Cancer Biomark.
12:73–79. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Agur Z, Kirnasovsky OU, Vasserman G,
Tencer-Hershkowicz L, Kogan Y, Harrison H, Lamb R and Clarke RB:
Dickkopf1 regulates fate decision and drives breast cancer stem
cells to differentiation: An experimentally supported mathematical
model. PLoS One. 6:e242252011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim Y, Kim H, Park D, Han M, Lee H, Lee
YS, Choe J, Kim YM and Jeoung D: miR-217 and CAGE form feedback
loop and regulates the response to anti-cancer drugs through EGFR
and HER2. Oncotarget. 7:10297–10321. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rachagani S, Macha MA, Menning MS, Dey P,
Pai P, Smith LM, Mo YY and Batra SK: Changes in microRNA (miRNA)
expression during pancreatic cancer development and progression in
a genetically engineered KrasG12D;Pdx1-Cre mouse (KC)
model. Oncotarget. 6:40295–40309. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gu L, Li H, Chen L, Ma X, Gao Y, Li X,
Zhang Y, Fan Y and Zhang X: MicroRNAs as prognostic molecular
signatures in renal cell carcinoma: A systematic review and
meta-analysis. Oncotarget. 6:32545–32560. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen DL, Zhang DS, Lu YX, Chen LZ, Zeng
ZL, He MM, Wang FH, Li YH, Zhang HZ, Pelicano H, et al:
microRNA-217 inhibits tumor progression and metastasis by
downregulating EZH2 and predicts favorable prognosis in gastric
cancer. Oncotarget. 6:10868–10879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang M, Cui G, Ding M, Yang W, Liu Y, Dai
1 and Chen L: miR-935 promotes gastric cancer cell proliferation by
targeting SOX7. Biomed Pharmacother. 79:153–158. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang AX, Lu FQ, Yang YP, Ren XY, Li ZF
and Zhang W: MicroRNA-217 overexpression induces drug resistance
and invasion of breast cancer cells by targeting PTEN signaling.
Cell Biol Int. Jun 24–2015.(Epub ahead of print). doi:
10.1002/cbin.10506. View Article : Google Scholar :
|
|
44
|
Wang W, Zhao LJ, Tan YX, Ren H and Qi ZT:
Identification of deregulated miRNAs and their targets in hepatitis
B virus-associated hepatocellular carcinoma. World J Gastroenterol.
18:5442–5453. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang W, Zhao LJ, Tan YX, Ren H and Qi ZT:
MiR-138 induces cell cycle arrest by targeting cyclin D3 in
hepatocellular carcinoma. Carcinogenesis. 33:1113–1120. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Su J, Wang Q, Liu Y and Zhong M: miR-217
inhibits invasion of hepatocellular carcinoma cells through direct
suppression of E2F3. Mol Cell Biochem. 392:289–296. 2014.
View Article : Google Scholar : PubMed/NCBI
|
